Check 35,000+ stocks against 26 valuation models and 37 quality factors

Charlotte's Web Holdings Inc (CWEB) fair value: what the stock is really worth

We calculate from audited financials what Charlotte's Web Holdings Inc is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

Valuation from Sep 13, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.

Fair value above price? No
Good quality? No
Add to watchlist

Healthcare · CA · ISIN CA16106R1091

CS Thin data Sep 13, 2026

Charlotte's Web Holdings Inc

CWEB · TO

Weakest SetupStrongly overvalued and low quality.

!Fair value C$0.0800 · Strongly overvalued (−80%)

!Quality 38/100

!Weak Growth (revenue 5y −12.1 %/yr)

!Loss-making · -75.1% net margin (TTM)

!Negative equity (buybacks among others) · negative free cash flow

!Trails peers (1/7)

!Narrow moat 10/100

!Evidence only low, so the estimate is less certain

26 models, one by oneBear C$0.0800 to bull C$0.0900 Growth analysisrevenue history, year by year Quality 38/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Charlotte's Web Holdings Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.

How to read this chart

60‑month range C$0.0900 – C$4.99 · fair‑value band C$0.0800 – C$0.0900 · the C$0.4050 price screens above the C$0.0800 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 13, 2026.

Follow Charlotte's Web Holdings in your weekly email

Every Wednesday you see whether Charlotte's Web Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and botanical-based wellness products in the United States.

Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and botanical-based wellness products in the United States. The company offers full-spectrum hemp extract oil tinctures, such as liquid products; gummies; capsules; soft-gels; CBD topical creams and lotions; broad-spectrum botanical CBD; functional mushroom gummies; and pet products. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids, and other beneficial hemp compounds. The company markets its products under the Charlotte's Web, Brightside, CBD Clinic, and CBD Medic brands. It distributes its products through its e-commerce website, third-party e-commerce websites, distributors, retailers, and healthcare practitioners. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was founded in 2013 and is headquartered in Louisville, Colorado.

Stock analysis

Charlotte's Web Holdings Inc (CWEB) currently trades at C$0.4050, while our model-based Fair Value estimate is C$0.0800, implying the stock looks roughly 406.3% overvalued today.

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: C$0.0800 (bear) to C$0.0900 (bull), the price of C$0.4050 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 38/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

Charlotte's Web Holdings Inc reported revenue of $49.9M in FY2025 versus $96.1M in FY2021, a compound −15.1%/yr. Reported net income was −$29.7M in FY2025.

Key figures

Market cap C$98.8M (≈ $70.0M) · P/S ratio 2.02 · EPS (TTM) C$−0.3300 · Net margin −59.6% · Return on equity −1,217% · Return on assets (EBIT) −39.1% · Operating margin −38.8% · Revenue (TTM) $48.8M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).

What moves the price

The share trades about 69% below its 52-week high and 238% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −8% fair-value upside, at −80%, CWEB screens richer than that median.

Notify me when CWEB reaches fair value

Put CWEB on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 38/100

Of which business quality 35 · Market factors (momentum, volatility) 39

Profitability 24

Margins and returns on capital today

Quality Growth 55

Are margins and returns improving?

Cashflow 0

Earnings quality: real cash, not paper profit

Fin. Strength 12

Balance sheet, leverage, solvency risk

Investment 100

Disciplined investing over empire-building

Low Volatility 0

Calm price path (market factor)

Momentum 51

Price trend over the last 3–12 months (market factor)

52W Momentum 62

Distance to the 52-week high (market factor)

Net Issuance 65

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 6/100

Revenue growth is weak: less than 2 % a year.

Revenue growth 1 year

+0.5%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

−12.4%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

−12.1%

Start year 2020 (pandemic)

Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+14.5%

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.

−53.9% (2020) → −40.6% (2025)

What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss

not computed

CWEB screens 406% overvalued. Compare with Merck KGaA →

Compare Charlotte's Web Holdings Inc with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 626 stocks

Beats the industry median on 1/7 measures

Overall it trails its industry peers.

Valuation

Quality Score 35 · Bottom 25%

Fair Value upside −80% · Bottom 25%

Profitability

Return on equity (TTM) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Return on assets −13% · Bottom 25%

Net margin (TTM) −75% · Bottom 25%

Operating margin (TTM) −39% · Bottom 25%

Growth and dividend

Revenue growth −9% · Bottom 25%

Balance sheet

Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

P/S (TTM) 1.43× · Cheaper than median

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
Merck KGaA MRK	€133.15	€108.70	−18%
Takeda Pharmaceutical Company TAK	$18.95	$11.29	−40%
Jiangsu Hengrui Pharmaceuticals Co 600276	¥45.58	¥50.14	+10%
Sun Pharmaceutical Industries Limited SUNPHARMA	₹1,865	₹1,979	+6%
Galderma Group GALD	CHF 163.80	CHF 109.88	−33%
Haleon plc HLN	$9.25	$8.50	−8%
Teva Pharmaceutical Industries Limited TEVA	$39.52	$20.75	−47%
Sandoz Group SDZ	CHF 70.76	CHF 40.16	−43%
Zoetis Inc ZTS	$72.86	$108.48	+49%
Hansoh Pharmaceutical Group 3692	HK$35.34	HK$38.87	+10%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Charlotte's Web Holdings Inc · Fair Value
C$0.0800 −406%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/CWEB" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Charlotte&#039;s Web Holdings Inc · Fair Value</span><br><b style="font-size:20px">C$0.0800</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−406%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Charlotte's Web Holdings Inc Fair Value". https://www.fairvalue-calculator.com/stock/CWEB

Frequently asked questions

Is Charlotte's Web Holdings Inc (CWEB) overvalued or undervalued?

As of Sep 13, 2026, our model estimates a fair value of C$0.0800 versus a price of C$0.4050, about −80% upside (overvalued).

What is the fair value of CWEB?

Our model-based fair value for Charlotte's Web Holdings Inc is C$0.0800 (as of Sep 13, 2026), built from audited fundamentals. The current price: C$0.4050.

What is the quality score of CWEB?

Charlotte's Web Holdings Inc has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Charlotte's Web Holdings Inc (CWEB)?

Our model-based price target is the fair value of C$0.0800 (as of Sep 13, 2026) from 2 valuation models. Cautious scenario C$0.0800, optimistic scenario C$0.0900. It is a calculation from audited fundamentals, not an analyst target.

What is the Charlotte's Web Holdings Inc stock forecast for 2026?

Our models put fair value at C$0.0800, about −80% upside versus a price of C$0.4050 (overvalued). Cautious scenario C$0.0800, optimistic scenario C$0.0900. The calculation is refreshed regularly with new filings.

What is the revenue of Charlotte's Web Holdings Inc (CWEB)?

Charlotte's Web Holdings Inc reported trailing-twelve-month revenue of about $48.8M (latest available figure, as of Sep 13, 2026).

What is the intrinsic value of Charlotte's Web Holdings Inc (CWEB)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Charlotte's Web Holdings Inc it is C$0.0800 per share (as of Sep 13, 2026), against a price of C$0.4050. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).

Is Charlotte's Web Holdings Inc stock overvalued or undervalued in 2026?

As of Sep 13, 2026, CWEB trades above its calculated fair value: price C$0.4050, fair value C$0.0800, a gap of about −80% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of CWEB?

No. The price is what the market pays today (C$0.4050); the fair value is what the company's own numbers justify (C$0.0800). For Charlotte's Web Holdings Inc the two are C$0.3250 per share apart. That gap is exactly why we show both numbers side by side.

How much is Charlotte's Web Holdings Inc worth?

The market values Charlotte's Web Holdings Inc at about C$98.8M (market capitalisation, as of Sep 13, 2026). Per share that is C$0.4050; our models calculate a fair value of C$0.0800 per share.

What do the bullish and bearish scenarios say about CWEB?

Our models span a range for Charlotte's Web Holdings Inc: cautious scenario C$0.0800, base C$0.0800, optimistic C$0.0900 per share (as of Sep 13, 2026, price C$0.4050). The range comes from different growth and margin assumptions, not from analyst opinions.

How solid is the balance sheet of Charlotte's Web Holdings Inc (CWEB)?

Balance-sheet figures for Charlotte's Web Holdings Inc (as of Sep 13, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 38/100, which measures business quality independently of the share price.

How far is CWEB from its 52-week high?

Charlotte's Web Holdings Inc trades at C$0.4050, about 69% below its 52-week high of C$1.29 and 238% above the low of C$0.1200 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of C$0.0800 is for.

Which stocks are comparable to Charlotte's Web Holdings Inc?

From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Jiangsu Hengrui Pharmaceuticals Co, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Charlotte's Web Holdings Inc stock attractive at the current price?

The data as of Sep 13, 2026: price C$0.4050, calculated fair value C$0.0800 (−80%), Quality Score 38/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of CWEB calculated?

We run Charlotte's Web Holdings Inc through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of C$0.0800, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.1 % above its aggregate fair value. Charlotte's Web Holdings Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Charlotte's Web Holdings Inc (CWEB)?

The closing price on Sep 23, 2026 was C$0.4050. Our model-based fair value is C$0.0800, about −80% upside (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Charlotte's Web Holdings Inc right now?

The price sits above even our optimistic bull case (C$0.0900). The favourable scenario is already priced in. Weak quality (38/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. The models converge in a tight band (C$0.0800 to C$0.0900), unusually little disagreement for a valuation.

Key figures of Charlotte's Web Holdings Inc

How large is the market capitalisation of Charlotte's Web Holdings Inc (CWEB)?

The market capitalisation of Charlotte's Web Holdings Inc is C$98.8M (≈ $70.0M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Charlotte's Web Holdings Inc (CWEB)?

The price-to-sales ratio of Charlotte's Web Holdings Inc is 2.02 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Charlotte's Web Holdings Inc (CWEB)?

Earnings per share at Charlotte's Web Holdings Inc are C$−0.3300. Earnings per share over the last twelve months: total profit spread across every single share.

What is the net margin of Charlotte's Web Holdings Inc (CWEB)?

The net margin of Charlotte's Web Holdings Inc is −59.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Charlotte's Web Holdings Inc (CWEB)?

The return on equity (ROE) of Charlotte's Web Holdings Inc is −1,217% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Charlotte's Web Holdings Inc (CWEB)?

On an EBIT basis the return on assets of Charlotte's Web Holdings Inc is −39.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Charlotte's Web Holdings Inc (CWEB)?

The operating margin of Charlotte's Web Holdings Inc is −38.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Charlotte's Web Holdings Inc (CWEB)?

Revenue at Charlotte's Web Holdings Inc is growing −9.0% versus a year earlier (3y avg −12.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How much free cash flow does Charlotte's Web Holdings Inc (CWEB) generate?

The free cash flow of Charlotte's Web Holdings Inc is −$14.7M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.

How much net debt does Charlotte's Web Holdings Inc (CWEB) carry?

The net debt of Charlotte's Web Holdings Inc is $56.4M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Charlotte's Web Holdings Inc in the live analysis

One click puts Charlotte's Web Holdings Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.